| scholarly article | Q13442814 |
| P356 | DOI | 10.1167/IOVS.07-0112 |
| P8608 | Fatcat ID | release_zblirofesbbs3cecbb4hqyixpy |
| P698 | PubMed publication ID | 17962481 |
| P5875 | ResearchGate publication ID | 5884362 |
| P50 | author | António Francisco Ambrósio | Q38326805 |
| Tetsuya Terasaki | Q39391558 | ||
| José Cunha-Vaz | Q40347268 | ||
| Ermelindo Leal | Q46592352 | ||
| P2093 | author name string | Ayyakkannu Manivannan | |
| John V Forrester | |||
| José Cunha-Vaz | |||
| Ken-Ichi Hosoya | |||
| António Francisco Ambrósio | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic retinopathy | Q631361 |
| P304 | page(s) | 5257-5265 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy | |
| P478 | volume | 48 |
| Q34600290 | 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase |
| Q50516135 | 670 nm red light preconditioning supports Müller cell function: evidence from the white light-induced damage model in the rat retina. |
| Q89976199 | A New Human Blood-Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes |
| Q36249969 | Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress |
| Q50095639 | Aflibercept in the treatment of diabetic macular edema: a review and consensus paper |
| Q37873482 | Anti-inflammatory therapy for diabetic retinopathy. |
| Q41285088 | Arginase as a mediator of diabetic retinopathy |
| Q46813458 | Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia |
| Q43230861 | Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats |
| Q39727356 | Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. |
| Q42123271 | Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy. |
| Q34919840 | CD40 promotes the development of early diabetic retinopathy in mice |
| Q37599453 | CaMKII regulates pericyte loss in the retina of early diabetic mouse |
| Q28584295 | Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes |
| Q34355343 | Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function |
| Q36145936 | Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy. |
| Q36477301 | Clocking in on diabetic retinopathy |
| Q60045483 | Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation |
| Q27007111 | Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases |
| Q38115020 | Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy? |
| Q33791268 | Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation. |
| Q26799423 | Dexamethasone intravitreal implant in the treatment of diabetic macular edema |
| Q28577516 | Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy |
| Q26749438 | Diabetic Macular Edema |
| Q58579972 | Diabetic Retinopathy: A complex pathophysiology requiring novel therapeutic strategies |
| Q26765466 | Diabetic Retinopathy: Animal Models, Therapies, and Perspectives |
| Q33713517 | Diabetic macular edema: new concepts in patho-physiology and treatment |
| Q39451009 | Diabetic retinopathy: Breaking the barrier |
| Q37184611 | Effect of Endomorphins on HUVECs Treated by ox-LDL and Its Related Mechanisms. |
| Q47124297 | Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration |
| Q34433667 | Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits |
| Q34077613 | Etiology and treatment of the inflammatory causes of cystoid macular edema |
| Q34047929 | Evaluation of leukocyte-endothelial interactions in retinal diseases |
| Q34790591 | Expression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells |
| Q33701506 | Folic Acid Treatment Normalizes NOS‐Dependence of Vascular Tone in the Metabolic Syndrome |
| Q26824541 | Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy |
| Q52903973 | Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats. |
| Q31083347 | Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity |
| Q39262816 | High glucose-induced proteome alterations in retinal pigmented epithelium cells and its possible relevance to diabetic retinopathy |
| Q38707676 | Histone HIST1H1C/H1.2 regulates autophagy in the development of diabetic retinopathy |
| Q26781909 | Immunopathogenic Background of Pars Planitis |
| Q34603026 | Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes |
| Q38746963 | Induction of oxidative and nitrosative stresses in human retinal pigment epithelial cells by all-trans-retinal |
| Q37911285 | Inflammation and diabetic retinal microvascular complications |
| Q37884176 | Inflammation in diabetic retinopathy |
| Q34615514 | Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse |
| Q55427105 | Intravitreal Bevacizumab Injection Attenuates Diabetic Retinopathy in Adult Rats with Experimentally Induced Diabetes in the Early Stage. |
| Q91362432 | Intravitreal injection of adenosine A2A receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice |
| Q41992574 | Loss of CD40 attenuates experimental diabetes-induced retinal inflammation but does not protect mice from electroretinogram defects |
| Q33645320 | Loss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse |
| Q36410673 | Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice |
| Q37096570 | Mechanisms of leukocyte migration across the blood-retina barrier |
| Q37658598 | Modes of Retinal Cell Death in Diabetic Retinopathy |
| Q34082890 | Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage |
| Q39948735 | Müller cells do not influence leukocyte adhesion to retinal endothelial cells |
| Q39416208 | Negative regulators of angiogenesis: important targets for treatment of exudative AMD. |
| Q46709448 | Neuropeptide Y stimulates retinal neural cell proliferation--involvement of nitric oxide |
| Q35071239 | Neurovascular interaction and the pathophysiology of diabetic retinopathy |
| Q37722105 | Niaspan inhibits diabetic retinopathy‑induced vascular inflammation by downregulating the tumor necrosis factor‑α pathway |
| Q28083676 | Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia |
| Q38845903 | Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches |
| Q28730878 | Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats |
| Q29248994 | Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy |
| Q49746282 | Panton-Valentine Leukocidin Colocalizes with Retinal Ganglion and Amacrine Cells and Activates Glial Reactions and Microglial Apoptosis |
| Q87843427 | Participation of the extrinsic cholinergic innervation in the action of nitric oxide on the ovarian steroidogenesis in the first proestrous in rats |
| Q36104687 | Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema |
| Q34575640 | Preconditioning with endoplasmic reticulum stress mitigates retinal endothelial inflammation via activation of X-box binding protein 1. |
| Q37526773 | Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells |
| Q36839005 | Promise of endothelial progenitor cell for treatment of diabetic retinopathy |
| Q34335696 | Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. |
| Q64251542 | Protective effect of myricetin derivatives from against hydrogen peroxide-induced stress in ARPE-19 cells |
| Q28564310 | Reduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications |
| Q43064763 | Reduction of inducible nitric oxide synthase via angiotensin receptor blocker prevents the oxidative retinal damage in diabetic hypertensive rats |
| Q38199105 | Regulation of claudins in blood-tissue barriers under physiological and pathological states |
| Q43442634 | Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas |
| Q99561828 | Retinal Physiology and Circulation: Effect of Diabetes |
| Q42141781 | Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse |
| Q37023057 | Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage |
| Q52731094 | Role of endoplasmic reticulum stress in 12/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy. |
| Q41012127 | Role of inflammation in the pathogenesis of diabetic retinopathy |
| Q34014053 | Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases |
| Q33914624 | Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein |
| Q48270894 | Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy |
| Q55317221 | Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes. |
| Q63435749 | Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy |
| Q34237700 | TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability |
| Q35005977 | TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis |
| Q51662239 | TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors. |
| Q64071750 | TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retina of streptozotocin-induced diabetic mice |
| Q34972210 | Targeting Neovascularization in Ischemic Retinopathy: Recent Advances |
| Q36184164 | Tetramethylpyrazine Protects Retinal Capillary Endothelial Cells (TR-iBRB2) against IL-1β-Induced Nitrative/Oxidative Stress |
| Q92538952 | The CD40-ATP-P2X 7 Receptor Pathway: Cell to Cell Cross-Talk to Promote Inflammation and Programmed Cell Death of Endothelial Cells |
| Q48308877 | The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration. |
| Q33769452 | The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy |
| Q40258168 | The effect of omega- 3 polyunsaturated fatty acids on endothelial tight junction occludin expression in rat aorta during lipopolysaccharide-induced inflammation |
| Q50798804 | The effect of ubiquinone and combined antioxidant therapy on oxidative stress markers in non-proliferative diabetic retinopathy: A phase IIa, randomized, double-blind, and placebo-controlled study. |
| Q35226462 | The kallikrein-kinin system in diabetic retinopathy |
| Q39244498 | The pathology associated with diabetic retinopathy. |
| Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
| Q33786878 | The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice |
| Q42373000 | Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy |
| Q36424494 | Triamcinolone acetonide prevents enhancement of hypoxia-induced neuronal and inducible nitric oxide synthases in the retinas of rats with oxygen-induced retinopathy |
| Q37121919 | Uveitic foveal atrophy: clinical features and associations |
| Q48768631 | VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases |
| Q53645908 | Vaccinium myrtillus extract prevents or delays the onset of diabetes--induced blood-retinal barrier breakdown. |
| Q34364177 | Validation of structural and functional lesions of diabetic retinopathy in mice |
| Q33625727 | Vascular dysfunction in retinopathy-an emerging role for arginase |
| Q36313749 | Vitreous levels of somatostatin in patients with chronic uveitic macular oedema |
| Q51266257 | Zerumbone, a Bioactive Sesquiterpene, Ameliorates Diabetes-Induced Retinal Microvascular Damage through Inhibition of Phospho-p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways. |
| Q47993537 | miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins |
Search more.